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vaccinated at birth. The mean size of TST indurations
observed was 7±4mm. Of the sample, 12 (2%) cases had
a positive TST. Association between observed factors are
explained in Table 1. Bacille Calmette-Gue´rin (BCG) showed
statistically signiﬁcance association with LTBI.
Conclusion: Prevalence of LTBI among healthy young adults
of Karachi is signiﬁcantly less at 2%. BCG was the only
associated factor identiﬁed. Medical students are at twice
the risk of acquiring the disease compared to their non
medical contemporaries.
Figure 1. Flow chart of study participants.
Table 1. Association of observed factors to latent tuberculosis disease
status among healthy young adults
Factors Positive TST,
n (%)
Negative TST,
n (%)
Uncertainty
coefﬁcient
(P-value)
Contingency
coefﬁcient
(P-value)
Gender
Male 2 (0.3) 202 (37.8) 0.007 0.067
Female 10 (1.8) 320 (59.9) (0.09) (0.12)
Institute
Medical 8 (1.4) 353 (66.1) 0.0001 0.003
Non medical 4 (0.7) 169 (31.6) (0.94) (0.94)
Ethnicity
Urdu speakers 9 (1.6) 352 (65.9) 0.001 0.024
Non-Urdu speakers 3 (0.5) 170 (31.8) (0.57) (0.58)
Own recent history
None 5 (0.9) 274 (51.3) 0.001 0.032
Possible 7 (1.3) 248 (46.4) (0.45) (0.45)
Own chronic
exposure
None 4 (0.7) 295 (55.2) 0.006 0.069
Possible 8 (1.4) 227 (42.5) (0.11) (0.11)
BCG vaccinated
Yes 10 (1.8) 519 (97.1) 0.104 0.240
No 2 (0.3) 3 (0.5) (0.00)* (0.0001)*
BCG, Bacille Calmette-Gue´rin; TST, Tuberculin skin test.
*Signiﬁcant.
PP-210 Utility of B cell epitopes based on peptides
of RD1 and RD2 mycobacterial antigens for
immunodiagnosis of pulmonary tuberculosis
B. Goyal1, D. Gupta1, R. Aggarwal1, K.K. Gupta1,
I. Verma1 *. 1Postgraduate Institute of Medical Education
and Research, Chandigarh, India
Background: Serodiagnostic tests incorporating highly
speciﬁc RD antigens from Mycobacterium tuberculosis
have recently been shown to be promising assays for
accurate diagnosis of both pulmonary and extrapulmonary
tuberculosis (TB). However only few of these studies
have used synthetic peptides and none has used them to
differentiate TB from Sarcoidosis, a close mimic of smear
negative pulmonary TB (PTB) with entirely different clinical
management.
Methods: Bioinformatics has emerged as a powerful tool
to predict amino acid sequence of immunodominant B cell
epitopes. In this study, Bcepred program was used to predict
B cell epitopes of immunodominant RD1 (ESAT6, CFP10)
and RD2 (CFP21, MPT64) antigens. Peptide corresponding to
these epitopes were got commercially synthesised and ELISA
was used as diagnostic technique to evaluate the reactivity
of these four peptides individually and in combination with
the sera of sputum smear +ve and sputum smear ve PTB
patients, Sarcoidosis patients and healthy controls taking
the mean + 3 SD of OD of entire healthy control group as
cut-off.
Results: Sensitivity with individual peptides ranged from
37.5%-83% for smear +ve, 25 58% for smear ve as compared
to 4 16% in sarcoidosis (a close mimic of PTB). However,
combination of all the four peptides resulted in 80%
sensitivity for smear +ve, 58.3% smear ve and only 4%
in sarcoidosis patients. In all these assays, speciﬁcity was
always observed to be 100% suggesting the highly speciﬁc
nature of RD peptides used in present study.
Conclusion: Thus, synthetic peptides corresponding to Bcell
epitopes of mycobacterial RD antigens can be used for
devising highly sensitive and speciﬁc TB diagnostic test
which can not only result in rapid diagnosis of smear positive
PTB but also detect a good proportion of otherwise difﬁcult
to diagnose sputum smear ve pulmonary TB with an ability
to differentiate from Sarcoidosis.
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Objective: To evaluate interferon gamma release assay
(TSPOT®.TB assay) and tuberculin skin test (TST) for
detecting latent tuberculosis infection (LTBI) among
patients with immune mediated inﬂammatory diseases
(IMID) prior to initiation of anti-TNF alpha therapy in BCG-
vaccinated area.
Methods: 294 IMID patients and 48 healthy controls from
Eastern China were enrolled. The TSPOT®.TB assay and TST
were performed on all subjects simultaneously. The positive
rates and odds ratio of risk factors were analyzed among
different subgroups.
Results: The positive rate of TSPOT assay was 27.2% and
that of TST was 51.4% (cut-off 5mm) or 38.4% (cut-
off 10mm) among IMID patients. Either in IMID patients
or in healthy controls, the TST positive rates were both
signiﬁcantly higher than that of TSPOT assay (P < 0.005).
TST positive rate in IMID patients was lower than in healthy
control. IMID patients are more likely to be misdiagnosed as
LTBI by TST. Among IMID patients, TST result was apparently
associated with BCG vaccination and immunosuppressive
therapy (P < 0.05) while TSPOT result was not.
Conclusion: TSPOT assay is a more reliable and sensitive
tool for screening LTBI among IMID patients in BCG-
vaccinated area, especially for those on immunosuppressive
therapy.
